These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 20732651)
1. Prospects for gene therapy in inflammatory arthritis. Jorgensen C; Apparailly F Best Pract Res Clin Rheumatol; 2010 Aug; 24(4):541-52. PubMed ID: 20732651 [TBL] [Abstract][Full Text] [Related]
2. Effects of treatment with small interfering RNA on joint inflammation in mice with collagen-induced arthritis. Schiffelers RM; Xu J; Storm G; Woodle MC; Scaria PV Arthritis Rheum; 2005 Apr; 52(4):1314-8. PubMed ID: 15818667 [TBL] [Abstract][Full Text] [Related]
3. Adeno-associated virus type 5-mediated intraarticular administration of tumor necrosis factor small interfering RNA improves collagen-induced arthritis. Khoury M; Courties G; Fabre S; Bouffi C; Seemayer CA; Vervoordeldonk MJ; Tak PP; Jorgensen C; Apparailly F Arthritis Rheum; 2010 Mar; 62(3):765-70. PubMed ID: 20187132 [TBL] [Abstract][Full Text] [Related]
4. Therapeutic silencing of an endogenous gene by siRNA cream in an arthritis model mouse. Takanashi M; Oikawa K; Sudo K; Tanaka M; Fujita K; Ishikawa A; Nakae S; Kaspar RL; Matsuzaki M; Kudo M; Kuroda M Gene Ther; 2009 Aug; 16(8):982-9. PubMed ID: 19474812 [TBL] [Abstract][Full Text] [Related]
5. Enhanced gene transfer to arthritic joints using adeno-associated virus type 5: implications for intra-articular gene therapy. Adriaansen J; Tas SW; Klarenbeek PL; Bakker AC; Apparailly F; Firestein GS; Jorgensen C; Vervoordeldonk MJ; Tak PP Ann Rheum Dis; 2005 Dec; 64(12):1677-84. PubMed ID: 15878906 [TBL] [Abstract][Full Text] [Related]
6. Efficient suppression of murine arthritis by combined anticytokine small interfering RNA lipoplexes. Khoury M; Escriou V; Courties G; Galy A; Yao R; Largeau C; Scherman D; Jorgensen C; Apparailly F Arthritis Rheum; 2008 Aug; 58(8):2356-67. PubMed ID: 18668557 [TBL] [Abstract][Full Text] [Related]
7. Gene therapy in rheumatic diseases. Vervoordeldonk MJ; Tak PP Best Pract Res Clin Rheumatol; 2001 Dec; 15(5):771-88. PubMed ID: 11812021 [TBL] [Abstract][Full Text] [Related]
8. Gene therapy as a therapeutic approach for the treatment of rheumatoid arthritis: innovative vectors and therapeutic genes. Adriaansen J; Vervoordeldonk MJ; Tak PP Rheumatology (Oxford); 2006 Jun; 45(6):656-68. PubMed ID: 16510530 [TBL] [Abstract][Full Text] [Related]
9. Short interfering RNA (siRNA): tool or therapeutic? Cejka D; Losert D; Wacheck V Clin Sci (Lond); 2006 Jan; 110(1):47-58. PubMed ID: 16336204 [TBL] [Abstract][Full Text] [Related]
10. RNA interference for therapy in the vascular endothelium. Kaufmann J; Ahrens K; Santel A Microvasc Res; 2010 Sep; 80(2):286-93. PubMed ID: 20144624 [TBL] [Abstract][Full Text] [Related]
13. Technology insight: gene transfer and the design of novel treatments for rheumatoid arthritis. Moritz F; Distler O; Ospelt C; Gay RE; Gay S Nat Clin Pract Rheumatol; 2006 Mar; 2(3):153-62. PubMed ID: 16932675 [TBL] [Abstract][Full Text] [Related]
14. Amphoteric liposomes enable systemic antigen-presenting cell-directed delivery of CD40 antisense and are therapeutically effective in experimental arthritis. Andreakos E; Rauchhaus U; Stavropoulos A; Endert G; Wendisch V; Benahmed AS; Giaglis S; Karras J; Lee S; Gaus H; Bennett CF; Williams RO; Sideras P; Panzner S Arthritis Rheum; 2009 Apr; 60(4):994-1005. PubMed ID: 19333921 [TBL] [Abstract][Full Text] [Related]
15. Intra-articular lentivirus-mediated delivery of galectin-3 shRNA and galectin-1 gene ameliorates collagen-induced arthritis. Wang CR; Shiau AL; Chen SY; Cheng ZS; Li YT; Lee CH; Yo YT; Lo CW; Lin YS; Juan HY; Chen YL; Wu CL Gene Ther; 2010 Oct; 17(10):1225-33. PubMed ID: 20520649 [TBL] [Abstract][Full Text] [Related]
16. Developing the concept of adoptive cellular gene therapy of rheumatoid arthritis. Tarner IH; Neumann E; Gay S; Fathman CG; Müller-Ladner U Autoimmun Rev; 2006 Feb; 5(2):148-52. PubMed ID: 16431349 [TBL] [Abstract][Full Text] [Related]
17. RNAi in arthritis: prospects of a future antisense therapy in inflammation. Khoury M; Jorgensen C; Apparailly F Curr Opin Mol Ther; 2007 Oct; 9(5):483-9. PubMed ID: 17932812 [TBL] [Abstract][Full Text] [Related]
18. Adenoviral delivery of IL-1 receptor antagonist abrogates disease activity during the development of autoimmune arthritis in IL-1 receptor antagonist-deficient mice. Hur W; Cho ML; Yoon SK; Kim SY; Ju JH; Jhun JY; Heo SB; Moon YM; Min SY; Park SH; Kim HY Immunol Lett; 2006 Aug; 106(2):154-62. PubMed ID: 16793145 [TBL] [Abstract][Full Text] [Related]
19. Concurrent gene therapy strategies effectively destroy synoviocytes of patients with rheumatoid arthritis. Terzioglu E; Bisgin A; Sanlioglu AD; Ulker M; Yazisiz V; Tuzuner S; Sanlioglu S Rheumatology (Oxford); 2007 May; 46(5):783-9. PubMed ID: 17309888 [TBL] [Abstract][Full Text] [Related]
20. In vivo delivery of lentiviral vectors expressing vasoactive intestinal peptide complementary DNA as gene therapy for collagen-induced arthritis. Delgado M; Toscano MG; Benabdellah K; Cobo M; O'Valle F; Gonzalez-Rey E; Martín F Arthritis Rheum; 2008 Apr; 58(4):1026-37. PubMed ID: 18383372 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]